COVID-19: immunology, immunopathogenesis and potential therapies
Abstract The Coronavirus Disease-2019 (COVID-19) imposed public health emergency and
affected millions of people around the globe. As of January 2021, 100 million confirmed …
affected millions of people around the globe. As of January 2021, 100 million confirmed …
Exploring Plausible Therapeutic Targets for Alzheimer's Disease using Multi-omics Approach, Machine Learning and Docking
SA Parvathy Dharshini, NP Sneha… - Current Topics in …, 2022 - benthamdirect.com
The progressive deterioration of neurons leads to Alzheimer's disease (AD), and developing
a drug for this disorder is challenging. Substantial gene/transcriptome variability from …
a drug for this disorder is challenging. Substantial gene/transcriptome variability from …
Exploring plausible therapeutic targets for Alzheimer's disease using multi-omics approach, machine learning and docking.
PD SA, NP Sneha, D Yesudhas… - Current Topics in …, 2022 - europepmc.org
The progressive deterioration of neurons leads to Alzheimer's disease (AD), and developing
a drug for this disorder is challenging. Substantial gene/transcriptome variability from …
a drug for this disorder is challenging. Substantial gene/transcriptome variability from …
Эффективность применения кортикостероидов в лечении госпитализированных пациентов с новой коронавирусной инфекцией (COVID-19)
ДО Ефремов, ВБ Белобородов, ИА Ковалев… - Терапия, 2021 - elibrary.ru
Цель исследования-изучение эффективности короткого курса применения
кортикостероидов у пациентов со среднетяжелым течением COVID-19 в отношении …
кортикостероидов у пациентов со среднетяжелым течением COVID-19 в отношении …
[PDF][PDF] Применение кортикостероидных гормонов у пациентов со среднетяжёлым течением COVID-19: какие цели могут быть достигнуты
ДО Ефремов, ВБ Белобородов… - Эпидемиология и …, 2021 - scholar.archive.org
АННОТАЦИЯ Обоснование. Имеются убедительные доказательства эффективности
глюкокортикоидов (дексаметазона) в лечении больных COVID-19 в критическом …
глюкокортикоидов (дексаметазона) в лечении больных COVID-19 в критическом …
Use of corticosteroid hormones in patients with moderate COVID-19: what goals can be achieved
DO Efremov, VB Beloborodov, AV Meshkov - Epidemiology and Infectious …, 2021 - rjeid.com
BACKGROUND: There is strong evidence of the effectiveness of glucocorticoids
(dexamethasone) in the treatment of critically ill patients with COVID-19. However, the …
(dexamethasone) in the treatment of critically ill patients with COVID-19. However, the …
Efficacy of corticosteroids in treatment of hospitalized patients with novel coronavirus infection (COVID-19)
DO Efremov, VB Beloborodov, IA Kovalev… - Therapy, 2021 - journals.eco-vector.com
The aim of the study was the examination of the efficacy of a short corticosteroid usage
course in patients with moderate COVID-19 run relatively to the dynamics of generalized …
course in patients with moderate COVID-19 run relatively to the dynamics of generalized …